Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 1Lymphatic Metastasis 1Communicable Diseases 1

Interventions

Magnetic Resonance Spectroscopy 4Specimen Handling 3Radiotherapy, Intensity-Modulated 2Radiosurgery 2Indocyanine Green 2Conversion to Open Surgery 2Cisplatin 2Artificial Intelligence 2tislelizumab 1radium Ra 223 dichloride 1peposertib 1pembrolizumab 1lncRNA LNMAT1, human 1encorafenib 1cabozantinib 1binimetinib 1avelumab 1alovudine 1X-Rays 1Technetium-99 1Technetium 1Surgical Procedures, Operative 1Sentinel Lymph Node Biopsy 1Robotic Surgical Procedures 1Radiotherapy 1Radiation Dose Hypofractionation 1Propranolol 1Platinum Compounds 1Platinum 1Pemetrexed 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphatic Metastasis × lncRNA LNMAT1, human × 1 year × Clear all
NCT07161921 2025-09-09

Gut Microbiota and Metabolite Signatures Associated With Lymph Node Metastasis in Pancreatic Cancer

Peking Union Medical College Hospital

Completed
55 enrolled
Gastrointestinal

Communicable Diseases, Lymphatic Metastasis, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡